IBB · iShares Biotechnology ETF
$198.26
-0.68 (-0.34%)
At close · Aug 14
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$198.26
Open$198.15
Day$195.67–198.28
52W close$137.07–200.72
Avg vol 30d1.5M
Short int10.0M · 7.1d
Short vol57%
DataJan 2020–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+14%
above
Price vs 50-day avg
+6%
above
RSI (14)
63
neutral
MACD trend
Positive
52-week position
96%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+4%
trailing
6-month return
+13%
trailing
YTD return
+17%
this year
Relative strength
−1%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $186 › 200d $174 — 50d above 200d
Institutional flow
Distributing
-67% holders QoQ · +44 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
▼ -15.7% MoM · 7.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
302 holders — near 3-yr low, contrarian setup
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
20%
annualized · 1-yr
Max drawdown
−10%
past year
ATR
1.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+14%
Bullish
Price vs 50-day avg
+6%
Bullish
RSI (14)
63
Neutral
MACD trend
Positive
Bullish
52-week position
96%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $186 › 200d $174 — 50d above 200d
Institutional flow
Distributing
-67% holders QoQ · +44 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
▼ -15.7% MoM · 7.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
302 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $137
Now $198 · 96%
Range high $201
vs 200-day avg +14%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
At a glance
key data from every sectionOwnership
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IBB | +0.3% | +4.5% | +13.2% | +6.4% | +17.5% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -0.1% | +0.0% | -0.5% | +2.4% | +3.6% |
Capital returns
Latest dividend
$0.024
/ share · ex Jun 15, 2026
Paid (TTM)
$0.412
/ share · 4 payouts
Dividend yield (TTM, derived)
0.21%
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
918509
CUSIP
464287556
13F (30d)
307 filings
304 filers